425: Strive CEO Comments on Semler Scientific Merger

Strive Inc.'s CEO Matthew Cole posted on X.com regarding the company's proposed business combination with Semler Scientific Inc.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication references a post made by Strive's CEO, Matthew Cole, on X.com on September 23, 2025, concerning the merger.
• The filing includes a comprehensive cautionary statement regarding forward-looking statements, highlighting numerous risks and uncertainties associated with the proposed transaction.
• It outlines the process for obtaining additional information, including the upcoming Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus.
• The document clarifies that Strive and Semler Scientific, along with certain directors and executive officers, may be deemed participants in the solicitation of proxies for the merger.

Sentiment

Score: 5

Explanation: The filing is a neutral legal disclosure about a proposed merger, but the extensive list of risks and cautionary statements balances any implied positive sentiment from the merger announcement itself. It's neither overtly positive nor negative, but rather a necessary regulatory communication.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the business combination.

Negatives

• The proposed transaction may not close as expected or at all due to unfulfilled conditions.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The transaction may be more expensive or take longer to complete than expected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business/employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific due to various circumstances.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• Legal proceedings may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the combined company.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the combined company's results.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including anticipated strategic and financial benefits, expected impact on future financial performance, timing of closing, and successful integration of businesses. However, it heavily cautions that actual results could differ materially due to various risks and uncertainties.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted on X.com on September 23, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing specifically mentions "implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets" as a factor that could affect the realization of anticipated benefits. This indicates a strategic focus on digital assets, which is a notable trend in certain sectors, and highlights the associated volatility and regulatory risks.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is available in its definitive proxy statement for the 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their relationships due to the merger announcement or completion.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance